lidocaine has been researched along with Bone Neoplasms in 12 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine whether systemic administration of QX-314 reduces bone cancer pain through selective inhibition of transient receptor potential vanilloid subfamily 1 (TRPV1)-expressing afferents." | 7.83 | Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice. ( Fuseya, S; Kawamata, M; Kawamata, T; Minemura, H; Yamamoto, K; Yamaori, S, 2016) |
| " The results showed that the patients in the study group had low intraoperative bleeding, short operation time, low postoperative hematoma formation rate, high patient satisfaction, higher dosage of anesthetic solution, and low dosage of lidocaine." | 5.72 | Clinical Application of Artificial Intelligence: Auto-Discerning the Effectiveness of Lidocaine Concentration Levels in Osteosarcoma Femoral Tumor Segment Resection. ( Li, X; Ni, S; Yi, X, 2022) |
| "The aim of this study was to determine whether systemic administration of QX-314 reduces bone cancer pain through selective inhibition of transient receptor potential vanilloid subfamily 1 (TRPV1)-expressing afferents." | 3.83 | Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice. ( Fuseya, S; Kawamata, M; Kawamata, T; Minemura, H; Yamamoto, K; Yamaori, S, 2016) |
| "A controlled double-blind investigation was undertaken in which ten patients with painful bone metastases were treated with intravenous lignocaine in a dosage of 5 mg/kg body-weight infused over a period of 30 minutes or the same volume of isotonic saline." | 2.66 | [Intravenous lidocaine in the treatment of chronic pain caused by bone metastases]. ( Banning, AM; Gefke, K; Hebsgaard, K; Petersen, P; Sjøgren, P, 1989) |
| " The results showed that the patients in the study group had low intraoperative bleeding, short operation time, low postoperative hematoma formation rate, high patient satisfaction, higher dosage of anesthetic solution, and low dosage of lidocaine." | 1.72 | Clinical Application of Artificial Intelligence: Auto-Discerning the Effectiveness of Lidocaine Concentration Levels in Osteosarcoma Femoral Tumor Segment Resection. ( Li, X; Ni, S; Yi, X, 2022) |
| "Cancer-induced bone pain is described as dull, aching ongoing pain." | 1.42 | Behavioral and neurochemical analysis of ongoing bone cancer pain in rats. ( King, T; Navratilova, E; Okun, A; Porreca, F; Remeniuk, B; Sukhtankar, D; Xie, JY, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, S | 1 |
| Li, X | 1 |
| Yi, X | 1 |
| Mirshahidi, S | 1 |
| Shields, TG | 1 |
| de Necochea-Campion, R | 1 |
| Yuan, X | 1 |
| Janjua, A | 1 |
| Williams, NL | 1 |
| Mirshahidi, HR | 1 |
| Reeves, ME | 1 |
| Duerksen-Hughes, P | 1 |
| Zuckerman, LM | 1 |
| Remeniuk, B | 2 |
| King, T | 2 |
| Sukhtankar, D | 2 |
| Nippert, A | 1 |
| Li, N | 1 |
| Li, F | 1 |
| Cheng, K | 1 |
| Rice, KC | 1 |
| Porreca, F | 2 |
| Berna, C | 1 |
| Luthy, C | 1 |
| Samer, CF | 1 |
| Spechbach, H | 1 |
| Pautex, S | 1 |
| Piguet, V | 1 |
| Okun, A | 1 |
| Navratilova, E | 1 |
| Xie, JY | 1 |
| Fuseya, S | 1 |
| Yamamoto, K | 1 |
| Minemura, H | 1 |
| Yamaori, S | 1 |
| Kawamata, T | 1 |
| Kawamata, M | 1 |
| Buchanan, DD | 1 |
| J MacIvor, F | 1 |
| Rousseff, RT | 1 |
| Simeonov, S | 1 |
| Wilhelm, IR | 1 |
| Griessinger, N | 1 |
| Koppert, W | 1 |
| Sittl, R | 1 |
| Likar, R | 1 |
| Colvin, L | 1 |
| Fallon, M | 1 |
| Zweig, JI | 1 |
| Malspies, L | 1 |
| Kaur, S | 1 |
| Kabakow, B | 1 |
| Sjøgren, P | 1 |
| Banning, AM | 1 |
| Hebsgaard, K | 1 |
| Petersen, P | 1 |
| Gefke, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic[NCT04043624] | Phase 4 | 80 participants (Anticipated) | Interventional | 2019-08-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lidocaine and Bone Neoplasms
| Article | Year |
|---|---|
[Intravenous lidocaine in the treatment of chronic pain caused by bone metastases].
Topics: Adult; Aged; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infusion | 1989 |
11 other studies available for lidocaine and Bone Neoplasms
| Article | Year |
|---|---|
Clinical Application of Artificial Intelligence: Auto-Discerning the Effectiveness of Lidocaine Concentration Levels in Osteosarcoma Femoral Tumor Segment Resection.
Topics: Adolescent; Artificial Intelligence; Bone Neoplasms; Child; Femoral Neoplasms; Femur; Humans; Lidoca | 2022 |
Bupivacaine and Lidocaine Induce Apoptosis in Osteosarcoma Tumor Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Bupivacain | 2021 |
Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain.
Topics: Adenocarcinoma; Analgesics; Analysis of Variance; Anesthetics, Local; Animals; Bone Neoplasms; Bufan | 2018 |
[Efficient treatment of breakthrough pain in adults: the importance of timing and medication choice].
Topics: Administration, Cutaneous; Aged; Analgesics; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammato | 2013 |
Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.
Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Stero | 2015 |
Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice.
Topics: Anesthetics, Local; Animals; Behavior, Animal; Bone Neoplasms; Cyclic AMP Response Element-Binding P | 2016 |
A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life.
Topics: Aged; Anesthetics, Local; Back Pain; Bone Neoplasms; Humans; Infusions, Intravenous; Kidney Neoplasm | 2010 |
Intralesional treatment in painful rib metastases.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Anti-Inflammatory Agents; Bone Neoplasms; Humans | 2004 |
High doses of topically applied lidocaine in a cancer patient.
Topics: Administration, Topical; Anesthetics, Local; Bone Neoplasms; Humans; Lidocaine; Osteosarcoma; Pain; | 2005 |
Challenges in cancer pain management--bone pain.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Bone Diseases | 2008 |
A novel approach to the temporary control of intractable bone pain.
Topics: Bone Neoplasms; Drug Therapy, Combination; Humans; Injections; Lidocaine; Pain, Intractable; Penicil | 1980 |